Nicorandil
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Taipei Medical University WanFang Hospital
Overview
Nicorandil is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Nicorandil clinical trials
Explore related
Medical disclaimer. This page summarizes research about Nicorandil for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.